JPMorgan Chase & Co.
NYSE:JPMBanks - Diversified
-$5.58 today
- Market cap
- $860.71B
- Beta
- 1.00
- P/E (TTM)
- 15.5
- EPS (TTM)
- $21.12
- Dividend yield
- 1.80%
Volume 6.67M
Average 9.02M
JPM EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
JPMorgan Chase & Co.NYSE: JPM
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA dips below year-ago levels
Q3 FY2026 EBITDA of $20.13B fell 4.2% year over year, behind the +13.5% change in trailing-twelve-month EBITDA. Sequentially, it fell 32.5% from the prior quarter. Over 3 fiscal years it compounded at +15.2% a year.
Context
- EBITDA amounted to 29.1% of revenue in FY2025, down 1.6 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 11 analysts of $92.83B (+14.0%) for the fiscal year ending Dec 2026, a step up from the -1.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $20.13B-32.5% QoQ
- Last fiscal yearDec 2025
- $81.42B-1.9% YoY
- LTMSep 2026
- $92.28B+13.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -4.2% | +11.5% | +15.6 pp |
| 1 year | -1.9% | +14.0% | +16.0 pp |
| 3-year CAGR | +15.2% | +4.1% | -11.1 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 81.42B USD
- Year-over-year change
- -1.9%
- 4-year CAGR
- +4.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 81.42B | -1.9% |
| FY2024 | 2024-12-31 | 83.02B | +20.1% |
| FY2023 | 2023-12-31 | 69.12B | +29.9% |
| FY2022 | 2022-12-31 | 53.22B | -21.2% |
| FY2021 | 2021-12-31 | 67.49B | — |
EBITDA vs competitors
How JPM compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +13.5% is the 8th highest of 11, against a peer median of +34.5%.
- EBITDA amounts to 30.6% of revenue for JPM, versus a peer median of 24.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | ¥3.81T JPY | +47.6% | +25.6% | 26.6% | |
| LTM Sep 2026 | ¥1.99T JPY | +53.1% | +25.4% | 21.2% | |
| LTM Sep 2026 | $92.28B USD | +13.5% | +15.2% | 30.6% | |
| LTM Sep 2026 | $45.43B USD | +31.1% | +6.7% | 23.3% | |
| LTM Jun 2026 | $39.72B USD | +38.0% | +18.5% | 29.5% | |
| LTM Sep 2026 | $33.36B USD | +5.5% | +13.6% | 25.6% | |
| LTM Sep 2026 | $33.01B USD | +41.0% | +14.7% | 26.7% | |
| LTM Sep 2026 | $30.03B USD | +24.6% | +1.6% | 19.5% | |
| LTM Sep 2026 | $29.65B USD | +12.9% | +13.7% | 22.9% | |
| LTM Jun 2026 | €21.15B EUR | -5.6% | +6.2% | 23.4% | |
| LTM Jun 2026 | $21.15B USD | +97.9% | +4.2% | 27.8% | |
| Peer median (excluding JPM) | — | +34.5% | +13.7% | 24.5% | |
Competitors are the stored peer set for JPM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 127.24B | 153.82B | 236.27B | 270.79B | 279.75B |
| Cost of Revenue | (3.67B) | 32.43B | 90.6B | 112B | 112.14B |
| Gross Profit | 130.91B | 121.39B | 145.67B | 158.79B | 167.61B |
| Gross Margin | 102.9% | 78.9% | 61.7% | 58.6% | 59.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 41.6B | 45.55B | 51.06B | 56.33B | 60.02B |
| Operating Expenses | 71.34B | 75.23B | 84.06B | 83.7B | 95.01B |
| Depreciation & Amortization | 7.93B | 7.05B | 7.51B | 7.94B | 8.82B |
| EBITDA | 67.49B | 53.22B | 69.12B | 83.02B | 81.42B |
| EBITDA Margin | 53.0% | 34.6% | 29.3% | 30.7% | 29.1% |
| Operating Income | 59.56B | 46.17B | 61.61B | 75.08B | 72.6B |
| Operating Margin | 46.8% | 30.0% | 26.1% | 27.7% | 26.0% |
| Interest Income | 57.86B | 92.81B | 170.59B | 193.93B | 193.34B |
| Interest Expense | 5.55B | 26.1B | 81.32B | 101.35B | 97.9B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 59.56B | 46.17B | 61.61B | 75.08B | 72.6B |
| Pre-Tax Margin | 46.8% | 30.0% | 26.1% | 27.7% | 26.0% |
| Income Tax Expense | 11.23B | 8.49B | 12.06B | 16.61B | 15.55B |
| Net Income | 48.33B | 37.68B | 49.55B | 58.47B | 57.05B |
| Net Margin | 38.0% | 24.5% | 21.0% | 21.6% | 20.4% |
| EPS (Basic) | 15.39 | 12.10 | 16.25 | 19.79 | 20.05 |
| EPS (Diluted) | 15.36 | 12.09 | 16.23 | 19.75 | 20.02 |
| Weighted Avg Shares | 3.02B | 2.97B | 2.94B | 2.87B | 2.78B |
| Weighted Avg Shares (Diluted) | 3.03B | 2.97B | 2.94B | 2.88B | 2.78B |
JPMorgan Chase & Co.
NYSE:JPM
Intrinsic Alpha fair value
Locked
Current Price
$324.11
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.